59 Patents
- 0 cites
- 0 cites
- US125655302026Combination Therapy with Targeted 4-1BB (CD137) Agonists/anti-fap Binding Domain and Anti-cea/anti-cd3 Bispecific Antibody
Hoffmann-la Roche Inc.
0 cites - US124418122025Methods of Treating Cancer by Administering Tumor Necrosis Factor (TNF) Family Ligand Trimer-containing Antigen-binding Molecules
Hoffmann-la Roche Inc.
0 cites - US124198622025Use of a Cathepsin S Inhibitor Against the Formation of Anti-drug Antibodies
Hoffmann-la Roche Inc.
0 cites - 0 cites
- US123589972025Bispecific Anti-human A-beta/anti-human Transferrin Receptor Antibodies
HOFFMANN-LA ROCHE Inc.
0 cites - 0 cites
- US123311342025Trispecific Antibodies Specific for HER2 and a Blood Brain Barrier Receptor and Methods of Use
Hoffmann-la Roche Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- US122757942025Bispecific Antigen Binding Molecules Comprising Anti-fap Clone 212
Hoffmann-la Roche Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- US122028702025Antigen Binding Molecules Comprising a Trimeric TNF Family Ligand and Encoding Polynucleotides Thereof
Hoffmann-la Roche Inc.
0 cites - US121863922025Combination Therapy of an Anti CD20 Antibody with a BTK Inhibitor
Hoffmann-la Roche Inc.
0 cites - US121459942024Bispecific Antigen Binding Molecules Capable of Specific Binding to CD40 and to Fap
Hoffmann-la Roche Inc.
0 cites - 0 cites
- US121059502024Extensions to Global Keyboard Shortcuts for Computing Devices Having Multiple Display Regions
MICROSOFT TECHNOLOGY LICENSING, LLC
0 cites - 0 cites
- 0 cites
- US120794642024Predictive Gesture Optimizations for Moving Objects Across Display Boundaries
MICROSOFT TECHNOLOGY LICENSING, LLC
0 cites - US120730662024User Interface Transitions and Optimizations for Foldable Computing Devices
MICROSOFT TECHNOLOGY LICENSING, LLC
0 cites - US120730672024User Interface Transitions and Optimizations for Foldable Computing Devices
MICROSOFT TECHNOLOGY LICENSING, LLC
0 cites - 0 cites
- 0 cites
- US120384412024CAR-T Reporter Based Diagnostic Assays to Detect Tumor Antigens in Cancer Patients
Hoffmann-la Roche Inc.
0 cites - US120309522024Bispecific Anti-human Cd20/human Transferrin Receptor Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites - 0 cites
- 0 cites
- US120000642024Universal Reporter Cell Assay for Specificity Test of Novel Antigen Binding Moieties
HOFFMANN-LA ROCHE Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- US118650822024Combination Therapy of Pd-1-targeted IL-2 Variant Immunocytokines and Antibodies Against Human PD-L1
Hoffmann-la Roche Inc.
0 cites - 0 cites
- US118097022023Modeless Augmentations to a Virtual Trackpad on a Multiple Screen Computing Device
Microsoft Technology Licensing, LLC
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- US117409142023Positioning User Interface Components Based on Application Layout and User Workflows
MICROSOFT TECHNOLOGY LICENSING, LLC
0 cites - US117186802023Combination Therapy of Anti-cd20/anti-cd3 Bispecific Antibodies and 4-1BB (CD137) Agonists
Hoffmann-la Roche Inc.
0 cites - 0 cites
- 0 cites
- US116691642023Augmenting the Functionality of User Input Devices Using a Digital Glove
MICROSOFT TECHNOLOGY LICENSING, LLC
0 cites - US116393972023Bispecific Antibodies Specific for T-cell Activating Antigens and a Tumor Antigen and Methods of Use
Roche Glycart AG
0 cites - US116393942023Bispecific Antigen Binding Molecule for a Costimulatory TNF Receptor
Hoffmann-la Roche Inc.
0 cites - US116135872023Combination Therapy of T Cell Activating Bispecific Antigen Binding Molecules and PD-1 Axis Binding Antagonists
Hoffmann-la Roche Inc.
0 cites - 0 cites
- US116034112023Bispecific Anti-human Cd20/human Transferrin Receptor Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites - US115901282023Combination Therapy of a Type II Anti-cd20 Antibody with a Selective BCL-2 Inhibitor
ABBVIE Inc.
0 cites - 0 cites
- US115477482023Adoptive T-cell Therapy0 cites